NCT04253522

Brief Summary

This project aims to (1) define and characterize brain networks of cognitive flexibility amongst patients with frontal lesions; (2) quantify the effects of ecological cognitive trainings and brain stimulation on behavioral performance and brain networks; (3) identify predictive markers of effective rehabilitation (patients)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

February 4, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2022

Completed
Last Updated

July 19, 2023

Status Verified

July 1, 2023

Enrollment Period

2.9 years

First QC Date

January 31, 2020

Last Update Submit

July 17, 2023

Conditions

Keywords

Cognitive RehabilitationMental flexibilityEcological tasksFunctional ConnectivityElectroencephalogramTraumatic Brain InjuryCerebroVascular Accident

Outcome Measures

Primary Outcomes (1)

  • Evolution of performance at GAS (Goal Attainment scaling) in long term

    The main judgement criterion will be the evolution of performance at GAS (Goal Attainment Scaling) in the month following the cognitive training phase, according to the individual objectives defined at the beginning of the procedure with each patient, compared to the baseline phase

    The month following the cognitive training phase (TF+1)

Secondary Outcomes (3)

  • Evolution of performance at GAS (Goal Attainment scaling) in short term

    Just after the cognitive training phase (TF)

  • Reaction time when performing TEA battery: Test of Everyday Attention

    Before the cognitive training phase (T0), just after the cognitive training phase (TF) and the month following the cognitive training phase (TF+1)

  • Score at TEA battery: Test of Everyday Attention

    Before the cognitive training phase (T0), just after the cognitive training phase (TF) and the month following the cognitive training phase (TF+1)

Study Arms (3)

Arm 1 (early phase B)

EXPERIMENTAL

3 phases of cognitive training: Phase A1: rehabilitation program in standard ergotherapy during 3 weeks Phase B: cognitive training using Covirtua software and Transcranial random noise stimulation during 4 weeks Phase A2: return to the standard rehabilitation program in standard ergotherapy during 5 weeks

Behavioral: Cognitive training

Arm 2 (mid phase B)

EXPERIMENTAL

3 phases of cognitive training: Phase A1: rehabilitation program in standard ergotherapy during 4 weeks Phase B: cognitive training using Covirtua software and Transcranial random noise stimulation during 4 weeks Phase A2: return to the standard rehabilitation program in standard ergotherapy during 4 weeks

Behavioral: Cognitive training

Arm 3 (late phase B)

EXPERIMENTAL

3 phases of cognitive training: Phase A1: rehabilitation program in standard ergotherapy during 5 weeks Phase B: cognitive training using Covirtua software and Transcranial random noise stimulation during 4 weeks Phase A2: return to the standard rehabilitation program in standard ergotherapy during 3 weeks

Behavioral: Cognitive training

Interventions

Rehabilitation program in standard ergotherapy and cognitive training with Covirtua Software and Transcranial random noise stimulation

Arm 1 (early phase B)Arm 2 (mid phase B)Arm 3 (late phase B)

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Affiliated to social security
  • Signed informed consent
  • Mother tongue: French
  • Right handed (Edimburg Scale)
  • Frontal traumatic brain injury or stroke responsible for a dysexecutive syndrome assessed by the GREFEX battery.

You may not qualify if:

  • Claustrophobia
  • Addiction
  • Major Hearing or Visual loss
  • Hearing prosthesis
  • Metal intraocular implant
  • Cardiac prosthesis
  • High Blood pressure
  • Severe cardiac insufficiency
  • Uncompensated thyroid disorders
  • Major neuropsychological disorder
  • Family or personal history of epilepsy
  • Pregnancy
  • Female subject of childbearing age not receiving effective contraception.
  • Participation in another experimental protocol involving brain stimulation within the last 4 weeks
  • Person under the protection of justice, tutorship or curatorship
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universty hospital of Toulouse (Rangueil)

Toulouse, 31059, France

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticStroke

Interventions

Cognitive Training

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCerebrovascular DisordersVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Xavier De Boissezon, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: N of 1 Trials with multiple Baseline with 3 phases
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2020

First Posted

February 5, 2020

Study Start

February 4, 2020

Primary Completion

December 13, 2022

Study Completion

December 13, 2022

Last Updated

July 19, 2023

Record last verified: 2023-07

Locations